1. Home
  2. DRVN vs MLYS Comparison

DRVN vs MLYS Comparison

Compare DRVN & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Driven Brands Holdings Inc.

DRVN

Driven Brands Holdings Inc.

N/A

Current Price

$10.53

Market Cap

2.8B

ML Signal

N/A

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

N/A

Current Price

$27.01

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DRVN
MLYS
Founded
1972
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Automotive Aftermarket
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.4B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
DRVN
MLYS
Price
$10.53
$27.01
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$19.57
$47.33
AVG Volume (30 Days)
2.2M
1.0M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
59.82
N/A
EPS
0.69
N/A
Revenue
$2,339,588,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.10
N/A
P/E Ratio
$15.28
N/A
Revenue Growth
1.54
N/A
52 Week Low
$9.80
$10.44
52 Week High
$19.74
$47.65

Technical Indicators

Market Signals
Indicator
DRVN
MLYS
Relative Strength Index (RSI) 22.34 41.11
Support Level $9.80 $26.85
Resistance Level $15.91 $30.05
Average True Range (ATR) 0.59 1.76
MACD -0.25 0.08
Stochastic Oscillator 10.44 29.78

Price Performance

Historical Comparison
DRVN
MLYS

About DRVN Driven Brands Holdings Inc.

Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: